Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Outcomes of ventricular tachycardia ablation in patients with structural heart disease: The impact of electrical storm

B. Aldhoon, D. Wichterle, P. Peichl, R. Čihák, J. Kautzner,

. 2017 ; 12 (2) : e0171830. [pub] 20170210

Language English Country United States

Document type Journal Article

AIMS: To investigate predictors of long-term outcomes after catheter ablation (CA) for ventricular tachycardia (VT) and the impact of electrical storm (ES) prior to index ablation procedures. METHODS: We studied consecutive patients with structural heart disease and VT (n = 328; age: 63±12 years; 88% males; 72% ischaemic cardiomyopathy; LVEF: 32±12%) who had undergone CA. According to presenting arrhythmia at baseline, they were divided into ES (n = 93, 28%) and non-ES groups. Clinical predictors of all-cause mortality were investigated and a clinically useful risk score (SCORE) was constructed. RESULTS: During a median follow-up of 927 days (IQR: 564-1626), 67% vs. 60% of patients (p = 0.05) experienced VT recurrence in the ES vs. the non-ES group, respectively; and 41% vs. 32% patients died (p = 0.02), respectively. Five factors were independently associated with mortality: age >70 years (hazard ratio (HR): 1.6, 95% confidence interval (CI): 1.1-2.4, p = 0.01), NYHA class ≥3 (HR: 1.9, 95% CI: 1.2-2.9, p = 0.005), a serum creatinine level >1.3 mg/dL (HR: 1.6, 95% CI: 1.1-2.3, p = 0.02), LVEF ≤25% (HR: 2.4, 95% CI: 1.6-3.5, p = 0.00004), and amiodarone therapy (HR: 1.5, 95% CI: 1.0-2.2, p = 0.03). A risk SCORE ranging from 0-4 (1 point for either high-risk age, NYHA, creatinine, or LVEF) correlated with mortality. ES during index ablation independently predicted mortality only in patients with a SCORE ≤1. CONCLUSIONS: Advanced LV dysfunction, older age, higher NYHA class, renal dysfunction, and amiodarone therapy, but not ES, were predictors of poor outcomes after CA for VT in the total population. However, ES did predict mortality in a low-risk sub-group of patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031054
003      
CZ-PrNML
005      
20181022105357.0
007      
ta
008      
171025s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0171830 $2 doi
035    __
$a (PubMed)28187168
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Aldhoon, Bashar $u Department of Cardiology, Institute for Clinical and Experimental Medicine - IKEM, Prague, Czech Republic. $7 gn_A_00003665
245    10
$a Outcomes of ventricular tachycardia ablation in patients with structural heart disease: The impact of electrical storm / $c B. Aldhoon, D. Wichterle, P. Peichl, R. Čihák, J. Kautzner,
520    9_
$a AIMS: To investigate predictors of long-term outcomes after catheter ablation (CA) for ventricular tachycardia (VT) and the impact of electrical storm (ES) prior to index ablation procedures. METHODS: We studied consecutive patients with structural heart disease and VT (n = 328; age: 63±12 years; 88% males; 72% ischaemic cardiomyopathy; LVEF: 32±12%) who had undergone CA. According to presenting arrhythmia at baseline, they were divided into ES (n = 93, 28%) and non-ES groups. Clinical predictors of all-cause mortality were investigated and a clinically useful risk score (SCORE) was constructed. RESULTS: During a median follow-up of 927 days (IQR: 564-1626), 67% vs. 60% of patients (p = 0.05) experienced VT recurrence in the ES vs. the non-ES group, respectively; and 41% vs. 32% patients died (p = 0.02), respectively. Five factors were independently associated with mortality: age >70 years (hazard ratio (HR): 1.6, 95% confidence interval (CI): 1.1-2.4, p = 0.01), NYHA class ≥3 (HR: 1.9, 95% CI: 1.2-2.9, p = 0.005), a serum creatinine level >1.3 mg/dL (HR: 1.6, 95% CI: 1.1-2.3, p = 0.02), LVEF ≤25% (HR: 2.4, 95% CI: 1.6-3.5, p = 0.00004), and amiodarone therapy (HR: 1.5, 95% CI: 1.0-2.2, p = 0.03). A risk SCORE ranging from 0-4 (1 point for either high-risk age, NYHA, creatinine, or LVEF) correlated with mortality. ES during index ablation independently predicted mortality only in patients with a SCORE ≤1. CONCLUSIONS: Advanced LV dysfunction, older age, higher NYHA class, renal dysfunction, and amiodarone therapy, but not ES, were predictors of poor outcomes after CA for VT in the total population. However, ES did predict mortality in a low-risk sub-group of patients.
650    _2
$a senioři $7 D000368
650    _2
$a katetrizační ablace $x škodlivé účinky $7 D017115
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pooperační komplikace $x epidemiologie $7 D011183
650    _2
$a komorová tachykardie $x komplikace $x patologie $x chirurgie $7 D017180
650    _2
$a fibrilace komor $x komplikace $7 D014693
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wichterle, Dan $u Department of Cardiology, Institute for Clinical and Experimental Medicine - IKEM, Prague, Czech Republic.
700    1_
$a Peichl, Petr, $u Department of Cardiology, Institute for Clinical and Experimental Medicine - IKEM, Prague, Czech Republic. $d 1976- $7 xx0092197
700    1_
$a Čihák, Robert $u Department of Cardiology, Institute for Clinical and Experimental Medicine - IKEM, Prague, Czech Republic.
700    1_
$a Kautzner, Josef $u Department of Cardiology, Institute for Clinical and Experimental Medicine - IKEM, Prague, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 12, č. 2 (2017), s. e0171830
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28187168 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20181022105902 $b ABA008
999    __
$a ok $b bmc $g 1254647 $s 992081
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 12 $c 2 $d e0171830 $e 20170210 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20171025

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...